supported by the Research Start-up Funding for the First Affiliated Hospital of USTC(RC2021012);the Fundamental Research Funds for Central Universities(WK9110000004).
Metabolic dysfunction-associated steatotic liver disease(MASLD),formerly known as non-alcoholic fatty liver disease,has a high global prevalence and can progress to metabolic dysfunction-associated steatohepatitis,cir...
supported by the Doctoral Research Fund of Hubei University of Science and Technology,with project number Q201810.
Partial hepatectomy is a first-line treatment for hepatocellular carcinoma.Within 2 weeks following partial hepatectomy,specific molecular pathways are activated to promote liver regeneration.Nevertheless,residual mic...